XOMAP 25.73 Stock Price XOMA Corporation
Range: | 22.25-26.51 | Vol Avg: | 1734 | Last Div: | 2.16 | Changes: | 0.04 |
Beta: | 0.9 | Cap: | 0.35B | Currency: | USD | Exchange: | NASDAQ |
Sector: | Healthcare | IPO: | Wed Dec 16 2020 | Empoloyees: | 13 |
CUSIP: | 98419J305 | CIK: | 0000791908 | ISIN: | US98419J3059 | Country: | US |
CEO: | Mr. Owen P. Hughes Jr. | Website: | https://www.xoma.com |
XOMA Corporation operates as a biotechnology royalty aggregator in Europe, the United States, and the Asia Pacific. The company engages in helping biotech companies for enhancing human health. It acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceutical or biotechnology companies. The company focuses on early to mid-stage clinical assets primarily in Phase 1 and 2 with commercial sales potential that are licensed to partners. It has a portfolio with approximately 70 assets. XOMA Corporation was incorporated in 1981 and is headquartered in Emeryville, California.
The content provided on this site is for informational purposes only and does not constitute financial, investment, or professional advice. We are not registered investment advisors or financial planners, and we do not provide recommendations or advice on buying, selling, or holding any particular stocks or securities. Any investment decisions should be made based on your own research and consultation with a qualified financial professional. We are not responsible for any financial loss or damages incurred from reliance on the information provided on this site. Please invest responsibly and seek professional advice when needed.